Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, September 5, 2024
Courthouse News Service
Thursday, September 5, 2024 | Back issues
Courthouse News Service Courthouse News Service

Amphetamine trouble

BOSTON — The maker of Vyvanse successfully sought dismissal of a putative consumer protection class action, which was brought by a patient who says she was given medicine with less of the active ingredient in them than the label indicated. She received empty pills, and some were deficient in the amount of medication in them, but she could not show how this rose above to the level of a breach of warranty or deceptive practices, rather than a mere error or negligence.

Read the ruling here.

Categories / Briefs, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...